Montelukast Sodium ravone 6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(2S)-1

6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(2S)-1

It is usually prescribed for the treatment of high blood pressure in order to reduce the risk of stroke and heart attack

Chemical Name: N-(2-hydroxyethyl)-3-(6-{[4-(trifluoromethoxy)phenyl]amino}pyrimidin-4-yl)benzamide

Sunitinib also inhibits CD117 (c-KIT)

in bronchoalveolar lavage fluid

Montelukast Sodium ravone 6-difluoro-4-[3-(methylamino)propoxy]phenyl}-N-[(2S)-1Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Montelukast is a CysLT1 antagonist; it blocks the action of leukotriene D4 (and secondary ligands LTC4 and LTE4) on the cysteinyl leukotriene receptor CysLT1 in the lungs and bronchial tubes by binding to it. This reduces the bronchoconstriction otherwise caused by the leukotriene and results in less